Estradiol Completed Phase 3 Trials for Myocardial Ischemia / Coronary Heart Disease (CHD) / Cardiovascular Disease (CVD) / Heart Diseases / one to five years postmenopausal Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00000559Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
NCT03097120The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.